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Aim: In the last decade, an increase in the incidence of autoimmune thyroid disease in children has 
been observed. The aim of the study was to determine the incidence of thyroid disease in the 
pediatric population treated at the Pediatric Clinic in Osijek; to determine if there was a rise in thyroid 
disease incidence in pediatric population in the observed period; and to determine whether there 
was any association of certain factors with an increased incidence of thyroid disease. 
Methods: This study was a two-year retrospective study in two separately observed one-year 
periods (2010 and 2017). All patients with thyroid endocrinological disorders treated at the Pediatric 
Clinic of the University Hospital Centre Osijek were included in the study. Their medical records were 
used to obtain data. Differences between variables were tested by the χ2 test, Fisher's exact test 
and Mann-Whitney U test. The level of statistical significance was accepted for p <0.05. 
Results: There was a 2.4-fold increase in the approximate incidence of thyroid disease, 9.7-fold 
higher approximate incidence of autoimmune thyroiditis, 9.75-fold higher approximate incidence of 
unspecified hypothyroidism and a triple increase in the approximate incidence of non-toxic goiter. 
Other unspecified thyroid diseases are also statistically significantly on the rise. An analysis of factors 
such as anamnestic features, age, gender, comorbidities and other relevant data could not explain 
the increased incidence of thyroid disease. 
Conclusion: The incidence of thyroid disease has increased considerably in the observed years, 
following world trends. Efforts should be taken to clarify the mechanisms and factors involved in 
causing thyroid diseases in the pediatric population.  
(Tomic A, Puseljic S, Tomac V. Characteristics of Thyroid Disease in Pediatric Population. SEEMEDJ 
2020; 4(2); 77-87) 
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Introduction 
The normal thyroid secretes thyroid hormones - 
triiodothyronine (T3) and thyroxine (T4), which 
are crucial for normal growth and development, 
body temperature and regulation of energy 
levels. The basic functions of the thyroid 
hormones are regulation of oxidation in cells, 
stimulation of oxidative processes in which heat 
is generated, stimulation of protein synthesis, 
stimulation of growth and differentiation and 
acceleration of the metabolism of 
carbohydrates, fats and vitamins (1). 
Proper thyroid function is essential for early 
neurocognitive development, growth and 
development during childhood and 
adolescence (2). Optimal concentration of 
thyroid hormones is crucial, since a prolonged 
hypothyroid condition can result in a variety of 
disorders. Hypofunction of the thyroid gland 
occurring before the age of 2 usually leads to 
delayed maturation of the skeleton and the 
development of intellectual disability (1). On the 
other hand, hypothyroidism occurring after a 
period crucial for neurocognitive development 
can lead to a slowdown in linear growth and 
maturation of the skeleton, with no effect on 
cognitive development and obesity 
development (3, 4). Furthermore, 
hypothyroidism diagnosed in the late 
prepubertal years, which usually happens due to 
Hashimoto's thyroiditis, can delay the onset of 
puberty or lead to premature isosexual pseudo-
puberty (development of breasts and internal 
reproductive organs in girls and increased 
testicular volume without adrenarche in boys). 
Later in adolescence and young adulthood, 
hypothyroidism can lead to menstrual disorders, 
infertility and miscarriages (5, 6). Several dozens 
of diseases have an autoimmune origin and such 
diseases affect 5-7% of the world's population 
(7). Thyroid disorders are one of the most 
common endocrinological problems in children 
and adolescents. Autoimmune thyroid disease is 
estimated to be the most common 
organospecific autoimmune disease, affecting 
up to 5% of the general population and 0.3 to 
9.6% of the pediatric and adolescent population 
(8-10). 
Epidemiological studies have suggested an 
increase in the incidence of autoimmune 
diseases in Western societies over the last few 
decades (11). The rise in the incidence of 
autoimmune diseases raises the question of the 
factors that perpetuate it. Given a decreasing 
frequency of infections in Western countries, 
with an increase in the incidence of allergic 
disorders and neoplasms, which is accompanied 
by an increase in the incidence of autoimmune 
diseases, a hygiene hypothesis has been put 
forward (12). Concordance of autoimmune 
disease in identical twins is 12-67%, which also 
highlights the potential role of epigenetics in 
disease development (13). Over the last few 
decades, there have been significant changes in 
nutrition, the environment and exposure to 
pollution, environmental infections and stress 
management. Another study highlights the 
significance of tobacco smoking, psychological 
distress, iodine intake, intrauterine development, 
bacterial and viral infections and medications 
such as interferon (14). Therefore, with the 
previously established contribution of genetics, 
increasing attention is shifted on environmental 
factors and the lifestyle in Western countries 
(15). The link between the causative factors of 
autoimmune disease – genetics and the 
environment – has not yet been fully elucidated. 
Although much progress has been made in 
understanding the pathogenesis of autoimmune 
diseases, many questions remain unanswered. 
Numerous studies conducted both in clinical 
settings and in experimental models have 
shown that changes in posttranslational histone 
modifications and DNA methylation – two major 
epigenetic mechanisms – could potentially 
cause immune tolerance breakdown and the 
development of autoimmune diseases (16, 17). 
Therefore, autoimmune diseases actually reflect 
the complex interactions between gene 
variation and the environment (18). In most 
cases, the origin of the stimuli leading to 
epigenetic changes in patients with autoimmune 
diseases remains undefined, but may include 
different external (e.g. diet, sun exposure, 
chemicals, environment, medicines) and internal 
(e.g. aging, stress, sex hormones) stimuli. X-
linked genes are typically unmethylated (active) 
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in males, while females have one methylated 
and one unmethylated gene. Several molecules 
encoded on the X chromosome have also been 
found to play a significant role in the 
development of autoimmune diseases (7). An 
epigenetic link between diet and autoimmune 
diseases has also been observed, since certain 
foods provide donors of methyl groups 
(methionine, choline) and cofactors (folic acid, 
vitamin B12 and pyrodoxal phosphate), which are 
essential for DNA and histone methylation (19). In 
addition to nutrition, ultraviolet radiation has 
been shown to stimulate epigenetic changes 
involving the hypermethylation of numerous 
promoter genes, some of which have an 
immunosuppressive effect (20). Furthermore, 
studies conducted on twins have shown that, 
although identical twins are epigenetically 
minimally different at a young age, they happen 
to show numerous differences in DNA 
methylation and histone acetylation later in life 
(21, 22). Taken together, epigenetics has become 
increasingly important in the study of the 
etiopathogenesis of the entire spectrum of 
diseases, especially autoimmune disorders, and 
any new insights will be of great importance for 
a better understanding of this growing health 
problem.  
The objectives of present study were to 
determine the incidence of thyroid disease in the 
pediatric population treated at the Pediatric 
Clinic in Osijek; to determine if there was a rise of 
thyroid disease incidence in pediatric population 
in 2010 and 2017; and to determine whether 
there was any association of certain factors, such 
as anamnestic features, gender, comorbidities 
and other relevant factors, with an increased 
incidence of thyroid disease in childhood for a 
given period. 
Patients and Methods  
All pediatric patients treated at the Pediatric 
Clinic of the University Hospital Centre Osijek 
within the periods from January 1st 2010 to 
December 31st 2010 and from January 1st 2017 
to December 31st 2017 who were monitored for 
thyroid disorders were included in the study. 
Their medical records were used to obtain data.  
The data collected from medical records 
included age, sex, diagnoses of thyroid disease, 
status of thyroid hormones, presence/absence 
of thyroid gland specific anti-bodies, 
comorbidities, components of physical status 
and family history data. During a follow-up 
period, the same pediatric specialist and 
pediatric endocrinology subspecialist monitored 
and guided the patients. The criteria for inclusion 
of the subjects in the research were as follows: - 
Patient under the age of 18 treated at the 
Pediatric Endocrinology Outpatient Clinic in the 
periods from January 1st 2010 to December 31st 
2010 and from January 1st 2017 to December 
31st 2017; Patient has one of the following 
diagnoses of thyroid disease (Revision 10 of the 
International Classification of Diseases and 
Related Health Problems): congenital 
hypothyroidism E03.0 / E03.1, other unspecified 
hypothyroidism E03.9, non-toxic goiter E04, 
hyperthyroidism / thyrotoxicosis E05, 
autoimmune thyroiditis E06.3, unspecified 
thyroid disorder E07.9, postprocedural 
hypothyroidism E89.0, malignant thyroid 
neoplasm C73, and observation Z03. Based on 
the data of the total population in the Republic 
of Croatia, the incidence of new pediatric thyroid 
disease cases was estimated. Since there were 
no subjects over 14 years of age (specifically, in 
both years, the oldest ones were 12 years old), 
the data from the population register for ages 0-
14 were used (24). Due to the dynamics of 
population change and the inability to present 
current population values, the approximation of 
the population incidence was expressed at 95% 
confidence intervals. 
The study was approved by the Ethics 
Committee of the Faculty of Medicine Osijek. 
Statistical analysis 
Categorical data are represented by absolute 
and relative frequencies. Numerical data are 
described by the median and the limits of the 
interquartile range. Category variables 
differences were tested by the Hi-square test 
and, if necessary, by the Fisher’s exact test. 
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The normality of the distribution of numerical 
variables was tested by the Shapiro-Wilk test. 
Differences of the numerical variables between 
the two independent groups were tested with 
the Mann-Whitney U test. All P-values are two-
sided. The significance level was set to Alpha = 
0.05. MedCalc Statistical Software version 18.2.1 
(MedCalc Software bvba, Ostend, Belgium; 
http://www.medcalc.org; 2018) and SPSS (IBM 
Corp. Released 2013. IBM SPSS Statistics for 
Windows) were used for statistical analysis 
(Version 21.0. Armonk, NY: IBM Corp.). 
Results 
Categorical data are represented by absolute 
and relative frequencies. Numerical data are 
described by the median and the limits of the 
interquartile range. Category variables 
differences were tested by the Hi-square test 
and, if necessary, by the Fisher’s exact test. 
The normality of the distribution of numerical 
variables was tested by the Shapiro-Wilk test. 
Differences of the numerical variables between 
the two independent groups were tested with 
the Mann-Whitney U test. All P-values are two-
sided. The significance level was set to Alpha = 
0.05. MedCalc Statistical Software version 18.2.1 
(MedCalc Software bvba, Ostend, Belgium; 
http://www.medcalc.org; 2018) and SPSS (IBM 
Corp. Released 2013. IBM SPSS Statistics for 
Windows) were used for statistical analysis 
(Version 21.0. Armonk, NY: IBM Corp.). 
Table 1. Incidence of thyroid diseases by diagnosis during 2010 and 2017 















thyroiditis 9 11.65 5-33 88 113.91 91-26 <0.001 
Congenital 

















Hyperthyroidism 1 1.29 0-3 1 1.29 1-41 >0.999 
Non-toxic goiter 15 19.42 
10-
87 45 58.25 42-46 <0.001 
Other thyroid 
diseases 0 0.00 0-0 18 23.30 13-81 <0.001 
*Incidence per 100,000 inhabitants, C.I. – confidence interval 
 
Table 1 presents the incidence of thyroid 
diseases by diagnosis during 2010 and 2017 The 
number of newly diagnosed cases of 
autoimmune thyroiditis in 2010 was 9, 
accounting for the incidence of 11.65 per 100,000 
inhabitants aged 0-14, and in 2017, the number 
of newly diagnosed cases was 88, accounting 
for the incidence of 113 newly diagnosed 
children per 100,000 inhabitants. Such a 9.7-fold 
increase in incidence was found to be 
statistically significant (p <0.001). Also, there was 
a 9.75-fold increase in the incidence of 
unspecified hypothyroidism during the years 
mentioned. In 2010, the incidence of unspecified 
hypothyroidism was 5.18, and in 2017, 50.48 per 
100,000 inhabitants (p <0.001). A threefold 
increase in the incidence of non-toxic goiter was 
detected, with an incidence of 19.42 newly 
diagnosed children in 2010, compared to 58.25 
newly diagnosed children per 100,000 
inhabitants aged 0-14 (p <0.001). Other 
unspecified thyroid diseases are also on a 
statistically significant rise – no cases were 
reported in 2010, and in 2017, the incidence was 
23.3 new cases per 100,000 inhabitants aged 0-
14.  
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Table 2 presents distribution of patients in 
regard of nutritional status. There were no 
significant differences in relation to malnutrition, 
or normal nutrition and overweight/obesity 
among subjects examined in 2010 and 2017.  
Table 2. Distribution of subjects in relation to nutrition status 
 Number (%) of subjects 
P* 
Nutrition 2010 2017 Overall 
Malnourished 3 (5) 4 (2) 7 (3)  
Normal weight 36 (60) 117 (56) 153 (57) 
0.20 Overweight 12 (20) 33 (16) 45 (17) 
Obese 9 (15) 54 (26) 63 (24) 
Overall 60 (100) 208 (100) 268 (100)  
*Hi-square test 
Also, no significant differences were observed 
between two populations studied in terms of 
specific aspects of physical examination (i.e. 
characteristics of the skin, eyes, presence of 
palpitations, appetite, body mass and stool and 
urination, Table 3). 
Table 3. Subjects according to specific aspects of physical examination 
 Number (%) children 
P* 
2010 2017 Total 
Skin     
Regular moisture and warmth, 
without trembling 
67 (93) 186 (94) 253 (94) 
0.77 
Thyroid symptomatology 5 (7) 11 (6) 16 (6) 
Total 72 (100) 197 (100) 269 (100)  
Eyes     
Normal 69 (99) 196 (100) 265 (99.6) 
0.26 
Pathology 1 (1) 0 1 (0.4) 
Total 70 (100) 196 (100) 266 (100)  
Palpation     
Regular 46 (68) 132 (61) 178 (63) 
0.39 Enlarged 22 (32) 83 (39) 105 (37) 
Total 68 (100) 215 (100) 283 (100)  
Appetite     
Regular 68 (94) 151 (92) 219 (92) 
0.39 
Changed 4 (6) 14 (8) 18 (8) 
Total 72 (100) 165 (100) 237 (100)  
Body mass     
Constant 71 (99) 161 (98) 232 (98) 
>0.99 
Fluctuating 1 (1) 4 (2) 5 (2) 
Total 72 (100) 165 (100) 237 (100)  
Stool     
Regular 59 (89.4) 159 (94.6) 217 (93.1) 
>0.99 
Irregular 7 (10.6) 9 (5.4) 11 (4.7) 
Total 66 (100) 167 (100) 233 (100)  
Urination - regular 72 (100) 165 (100) 237 (100) - 
*Fisher’s exact test 
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Presence of family history of thyroid diseases 
was significantly more frequent in data collected 
in 2017; however, no difference was observed in 
terms of appearance in paternal, maternal or kin 
side (Table 4). Also, comorbidities were equally 
distributed between two studied groups of 
patients (Table 5).
Table 4. Subjects by family history and years observed 
 Number (%) children 
P* 
2010 2017 Total 
Family history     
Positive 23 (44) 107 (67) 130 (61) 
0.004† 
Negative 29 (56) 53 (33) 82 (39) 
Total 52 (100) 160 (100) 212 (100)  
Positive family history     
Maternal side 16 (73) 64 (65) 80 (61) 
0.06 
Paternal side 2 (9) 19 (19) 21 (16) 
Combined 
(brother/sister/maternal/paternal) 
4 (18) 15 (16) 19 (23) 
Total 23 (100) 107 (100) 130 (100)  
*Fisher’s exact test; †χ2 test 
 




subjects  P* 
 2010 2017 Total  
Obesity 1 (3.6) 22 (12.5) 23 (11.27) 0.213 
Polycystic ovary syndrome/ dysmenorrhea 0 (0) 4 (2.3) 4 (1.96) >0.999 
Haematological irregularities (↓Trc, anaemia) 0 (0) 4 (2.3) 4 (1.96) >0.999 
Skin disorders (acne, psoriasis, vitiligo, atopy) 0 (0) 7 (4) 7 (3.43) 0.597 
Respiratory diseases of allergic etiology 
(Allerg.rhinitis/bronchitis/asthma) 1 (3.6) 4 (2.3) 5 (2.45) 0.526 
JRA, polyarthralgia, Sy Raynaud 1 (3.6) 6 (3.4) 7 (3.43) >0.999 
Benign nodus 0 (0) 6 (3.4) 6 (2.94) >0.999 
Hypertension, heartbeat 
irregularities/palpitations 0 (0) 8 (4.5) 8 (3.92) 0.602 
Celiac disease 0 (0) 5 (2.8) 5 (2.45) >0.999 
Gastritis, GERB 0 (0) 2 (1.1) 2 (0.98) >0.999 
Trembling, vertigo, headache 1 (3.6) 11 (6.3) 12 (5.88) >0.999 
Epilepsy and epileptic convulsions 1 (3.6) 1 (0.6) 2 (0.98) 0.256 
Chromosomopathies (Sy Down, Sy Turner, Sy 
DiGeorge) 0 (0) 5 (2.8) 5 (2.45) >0.999 
Hypotrophy, retarded growth 0 (0) 6 (3.4) 6 (2.94) >0.999 
Accelerated growth, pubertas praecox 2 (7.1) 4 (2.3) 6 (2.94) 0.192 
Hyperlipidaemia 1 (3.6) 5 (2.8) 6 (2.94) 0.593 
*Fisher’s exact test 
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Discussion 
Based on the data of the total population in the 
Republic of Croatia, the incidence of newly 
diagnosed children with thyroid disease was 
estimated. Since no newly diagnosed subjects 
were over 14 years of age (specifically, in both 
years, the oldest newly diagnosed subject was 
12 years old), the data from the population 
register for ages 0-14 were used (24). Due to the 
peculiarity of the pediatric population of eastern 
Croatia, patients from Osijek-Baranja and 
Vukovar-Srijem counties gravitate mostly to the 
University Hospital Centre Osijek. For this 
reason, the 2010 census data for Osijek-Baranja 
County and Vukovar-Srijem County were used 
to approximate the incidence of newly 
diagnosed subjects, which totalled to 77,257 
children aged 0-14 (Osijek-Baranja: 46,806 
children, Vukovar-Srijem: 30,451 children). Due 
to the dynamics of population change and the 
inability to present current population values, 
the approximation of the population incidence 
was expressed at 95% confidence intervals. Our 
results suggest that the total number of newly 
diagnosed cases of thyroid disease has 
increased significantly. A similar trend in the 
incidence of thyroid disease has been reported 
in other studies (25). Looking at the incidence of 
thyroid disease by years, there is a statistically 
significant increase in the incidence of 
autoimmune thyroiditis, unspecified 
hypothyroidism, non-toxic goiter, and other 
unspecified thyroid diseases. The increase in the 
incidence of thyroid disease, especially 
autoimmune thyroid disease, is a global trend, 
present especially in Western countries, where 
the decrease of infectious diseases incidence is 
also being observed (11, 26). This research 
confirms that a similar trend can be observed in 
subjects. Furthermore, probably mostly due to 
the existence of screening for congenital 
hypothyroidism during the early neonatal 
period, figures regarding this diagnosis have not 
changed significantly over the years, and 
fortunately remained low. 
So far, numerous studies on gender and 
autoimmunity have concluded that thyroid 
diseases, such as autoimmune thyroiditis and 
goiter, are more common in women, as 
confirmed by this research. This pattern has 
been partially elucidated by the influence of 
female sex hormones and by X inactivation, but 
remains to be fully explained (27). In present 
study, subjects were analyzed regarding the 
nutrition status expressed by body mass index. 
Patients with chromosomopathies (Down 
Syndrome, DiGeorge Syndrome, Turner 
Syndrome) were excluded, since their growth 
and development do not follow the usual 
patterns. Subjects were classified into 4 groups 
depending on the centile - malnourished, 
normal weight, overweight and obese subjects. 
The study showed that the majority of subjects 
in both observed years had normal body weight 
(57%), 3% were malnourished, while 41% of 
subjects were overweight and obese. In both 
observed years, a large proportion of childre n 
were overweight and obese. In a 2010 study 
conducted on healthy Croatian school-age 
children, it was found that 69.9% of children were 
normal weight and 30.1% were overweight and 
obese (28). Taking into account the results of our 
study on the population of children suffering 
from thyroid disease, it is obvious that there is a 
slightly higher proportion of overweight and 
obese children (by 10.9%) among children with 
thyroid disorders than the population of healthy 
children, while the share of children with normal 
body weight was slightly lower (12.9%). Although 
statistically insignificant, it could suggest a 
higher incidence of thyroid disease among 
children of a higher body mass index, as 
explained by the interaction of metabolically 
active adipose tissue and leptin and the thyroid-
stimulating hormone (29). Specifically, adipose 
tissue plays a role in the pathophysiology of 
thyroid disorders. Fat cells produce leptin, which 
is why they are considered to be an active 
endocrine organ. Leptin is a potential link 
between the TSH and body mass index; it acts 
as a neuroendocrine regulator of the 
hypothalamus-pituitary-thyroid axis by 
regulating TSH gene expression in certain brain 
regions. Vice versa, the TSH stimulates leptin 
secretion in adipose tissue. Leptin also promotes 
the conversion of T4 to T3 (30). In obese children, 
elevated TSH and T4 levels have become a 
common finding. Since these values appear to 
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result from an elevated body mass index, it 
might be possible to normalize thyroid hormone 
levels by correcting or losing extra body weight. 
However, the incidence of thyroid antibodies is 
low in these patients, suggesting that adiposity 
via the previously explained association with 
leptin affects TSH levels, but not the thyroid 
antibody levels (31, 32). Obesity has become a 
growing public health problem. At the same 
time, it also appears to be a perpetuating factor 
in the increased incidence of thyroid disease. 
Other physical status data were also taken from 
the subjects' medical records to determine if 
there were significant changes between these 
variables in 2010 and 2017. By processing the 
data collected, it was concluded that there was 
no statistically significant difference between 
the variables observed in the years compared by 
which we could explain the increased incidence 
of thyroid disease. 
In addition to all other information, one of the 
characteristics of thyroid disease is certainly 
family clustering and a positive family history. A 
positive family history of thyroid disease in 2010 
was present in 44% of the subjects, while in 2017, 
this number increased statistically significantly 
to 67%. Given the invariability of the genetic 
component of the disease, the increase in the 
number of subjects with a positive family history 
could be explained by the greater awareness of 
patients with thyroid disease and cognition of 
similar diseases within their own families, but 
also by the indirectly increased incidence of 
thyroid disease in both the adult and pediatric 
populations (26). 
The most common comorbidities include 
obesity, diabetes mellitus type 1, cystic ovarian 
syndrome and dysmenorrhea, skin changes, 
respiratory diseases of allergic etiology, 
hypertension, palpitations, celiac disease, 
gastritis and GERD, chromosomopathies, 
praecox puberty and accelerated growth, which, 
according to available literature, have been 
previously linked to thyroid disease and thyroid 
hormone imbalance (33-42). However, the 
difference in the incidence of these 
comorbidities in the observed years was not 
found to be statistically significant. Such 
persistent co-occurence might suggest that 
there is a pathophysiological link between some 
of these diseases and autoimmune thyroid 
disease. 
Based on the research conducted and the 
analysis of the data obtained, several 
conclusions can be drawn. The incidence of 
thyroid disease in general, autoimmune 
thyroiditis, unspecified hypothyroidism and non-
toxic goiter increased multiple times in the 
observed period. Other unspecified thyroid 
diseases are also on the statistically significant 
rise. During the observed period, there was a 
statistically significant increase in the number of 
diseased female children compared to the male 
children in each year separately, but the ratio of 
the diseased did not change significantly during 
the observed years. Also, there were no 
significant differences in comorbidities in the 
subjects compared to the years observed, which 
could explain the increased incidence. The 
consistency of a positive family history in the 
direction of thyroid disease was confirmed, with 
the prevalence of a positive family history along 
the maternal line. 
Conclusion 
In conclusion, it is evident that autoimmune 
diseases in general are a local and global issue 
that will appear even more frequently in the 
future. With the aim of successful treatment and 
potential prevention, additional efforts are 
needed to determine the exact incidence and to 
identify potential risk factors for the 
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